Remove 2022 Remove Compounding Remove Generic Medicine
article thumbnail

Reuters Pharma 2022 – a day one overview – part 1

pharmaphorum

The Reuters Pharma event 2022 began as a bustling industry affair yesterday, based out of the Nice Acropolis convention centre on France’s balmy south coast. Indeed, of the 281 WHO-listed essential medicines, 100% of respiratory treatments are Teva’s. NB: Part 2 of ’Reuters Pharma 2022 – a day one overview’ will follow shortly….

article thumbnail

Small molecule API market to value $284.7 billion by 2032

European Pharmaceutical Review

billion in 2022. A compound annual growth rate (CAGR) growth of 5.9 The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses and rising demand for generic medicines. This is a rise from $162.8